Huaren Pharmaceutical Co Ltd Market Cap ($460.17 Million)
Market Cap & Net Worth: Huaren Pharmaceutical Co Ltd (300110)
Huaren Pharmaceutical Co Ltd market cap. Huaren Pharmaceutical Co Ltd (SHE:300110) has a market capitalization of $460.17 Million (CN¥3.14 Billion) as of November 8, 2026. Listed on the SHE stock exchange, this China-based company holds position #12333 globally and #3587 in its home market, demonstrating a 3.10% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Huaren Pharmaceutical Co Ltd's stock price CN¥2.66 by its total outstanding shares 1182212982 (1.18 Billion). Also see 300110 operating cash flow for how efficiently the company converts equity into cash flow.
Huaren Pharmaceutical Co Ltd Market Cap History (2015–2026)
Huaren Pharmaceutical Co Ltd market cap history from 2015 to 2026. Data shows change from $1.36 Billion to $460.17 Million (-7.07% CAGR). Check 300110 share price today for real-time trading data and today's change.
Huaren Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Huaren Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 300110 shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.41x
Huaren Pharmaceutical Co Ltd's market cap is 0.41 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.50 Billion | $1.25 Billion | $23.95 Million | 1.20x | 62.61x |
| 2017 | $2.02 Billion | $1.31 Billion | $37.54 Million | 1.54x | 53.73x |
| 2018 | $539.12 Million | $1.38 Billion | $38.79 Million | 0.39x | 13.90x |
| 2019 | $713.60 Million | $1.46 Billion | $42.07 Million | 0.49x | 16.96x |
| 2020 | $801.85 Million | $1.32 Billion | $94.62 Million | 0.61x | 8.47x |
| 2021 | $816.40 Million | $1.56 Billion | $130.40 Million | 0.52x | 6.26x |
| 2022 | $724.71 Million | $1.62 Billion | $180.78 Million | 0.45x | 4.01x |
| 2023 | $725.04 Million | $1.64 Billion | $188.06 Million | 0.44x | 3.86x |
| 2024 | $608.94 Million | $1.35 Billion | -$1.37 Billion | 0.45x | N/A |
| 2025 | $544.93 Million | $1.32 Billion | -$462.90 Million | 0.41x | N/A |
Competitor Companies of 300110 by Market Capitalization
Companies near Huaren Pharmaceutical Co Ltd in the global market cap rankings as of November 8, 2026. Also see total assets of Huaren Pharmaceutical Co Ltd for a full breakdown of the balance sheet.
Key companies related to Huaren Pharmaceutical Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #530 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #567 globally with a market cap of $47.07 Billion USD ( CN¥321.69 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #609 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #530 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.61 |
| #567 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $47.07 Billion | CN¥50.43 |
| #609 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.80 |
Market Capitalization of Huaren Pharmaceutical Co Ltd (2015–2026)
Market capitalization of Huaren Pharmaceutical Co Ltd from 2015 to today. Between 2015 and today, Huaren Pharmaceutical Co Ltd's market cap moved from $1.36 Billion to $ 460.17 Million, with a yearly change of -7.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥460.17 Million | -15.56% |
| 2025 | CN¥544.93 Million | -10.51% |
| 2024 | CN¥608.94 Million | -16.01% |
| 2023 | CN¥725.04 Million | +0.05% |
| 2022 | CN¥724.71 Million | -11.23% |
| 2021 | CN¥816.40 Million | +1.81% |
| 2020 | CN¥801.85 Million | +12.37% |
| 2019 | CN¥713.60 Million | +32.36% |
| 2018 | CN¥539.12 Million | -73.27% |
| 2017 | CN¥2.02 Billion | +34.51% |
| 2016 | CN¥1.50 Billion | +10.28% |
| 2015 | CN¥1.36 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Huaren Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $460.17 Million USD |
| MoneyControl | $460.17 Million USD |
| MarketWatch | $460.17 Million USD |
| marketcap.company | $460.17 Million USD |
| Reuters | $460.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Huaren Pharmaceutical Co Ltd
Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. It offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium, chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. The company also provides therape… Read more